Interactions between nitric oxide and prostanoids in isolated perfused kidneys of the rat

被引:22
作者
Ziyyat, A [1 ]
Zhang, BL [1 ]
Benzoni, D [1 ]
机构
[1] FAC PHARM LYON,URA CNRS 1483,DEPT PHYSIOL & PHARMACOL CLIN,F-69373 LYON 08,FRANCE
关键词
prostanoids; TP receptor; nitric oxide; isolated perfused kidney;
D O I
10.1111/j.1476-5381.1996.tb15998.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 The present study was aimed to assess the interaction between nitric oxide (NO) and thromboxane (Tx) A(2)-prostaglandin (PG) H-2 in single-pass perfused isolated kidneys of the rat. 2 Noradrenaline (NA, 63 and 110 nM) dose-dependently elevated the renal vascular resistance (RVR), the giomerular filtration rate (GFR) and the urinary excretion of sodium (UNaV). Infusion of N-omega-nitro-L-arginine methyl ester (L-NAME, 100 mu M), an inhibitor of NO synthesis, enhanced the effects of NA on RVR and on UNaV, but decreased those on GFR. The TxA(2)-PGH(2) (TP) receptor blockade by GR32191B (10 mu M) attenuated this potentiating effect of L-NAME. 3 When renal perfusion pressure was stepwise increased from 90 to 150 mmHg, L-NAME similarly decreased renal perfusion flow rate and GFR. 4 The venous excretion of TxB(2) and 6-keto-PGF(1 alpha) was increased by L-NAME in baseline conditions as well as after NA or increasing renal perfusion pressure (RPP). 5 These results suggest that: (1) TxA(2) and PGH(2) play an important role in the overall effect of the renal prostanoids, (2) NO strongly interacts with the cyclo-oxygenase pathway and reduces the prostanoid synthesis in the kidney, and (3) the presser effect of L-NAME partly relies upon the vasoconstrictor effect of TxA(2) and PGH(2).
引用
收藏
页码:388 / 392
页数:5
相关论文
共 24 条
[1]   MODULATION OF PROSTACYCLIN THROMBOXANE FORMATION BY MOLSIDOMINE DURING PLATELET ENDOTHELIAL-CELL INTERACTIONS [J].
BORDET, JC ;
LAGARDE, M .
BIOCHEMICAL PHARMACOLOGY, 1988, 37 (20) :3911-3914
[2]  
COLEMAN RA, 1980, BRIT J PHARMACOL, V68, P127
[3]   INTRARENAL HEMODYNAMIC AND GLOMERULAR RESPONSES TO INHIBITION OF NITRIC-OXIDE FORMATION IN RABBITS [J].
DENTON, KM ;
ANDERSON, WP .
JOURNAL OF PHYSIOLOGY-LONDON, 1994, 475 (01) :159-167
[4]  
ESCALANTE B, 1989, J PHARMACOL EXP THER, V248, P299
[5]   HEMODYNAMIC AND TUBULAR EFFECTS OF ENDOTHELIN AND THROMBOXANE IN THE ISOLATED PERFUSED RAT-KIDNEY [J].
FERRARIO, RG ;
FOULKES, R ;
SALVATI, P ;
PATRONO, C .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 171 (01) :127-134
[6]   ROLE OF NITRIC-OXIDE IN EICOSANOID SYNTHESIS AND UTERINE MOTILITY IN ESTROGEN-TREATED RAT UTERI [J].
FRANCHI, AM ;
CHAUD, M ;
RETTORI, V ;
SUBURO, A ;
MCCANN, SM ;
GIMENO, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (02) :539-543
[7]  
GABBAI F B, 1992, Journal of the American Society of Nephrology, V3, P561
[8]  
GEOFFROY J, 1985, PROSTA LEUKOTR MED, V18, P393, DOI 10.1016/0262-1746(85)90072-1
[9]   INTERACTIONS BETWEEN NITRIC-OXIDE AND PROSTACYCLIN [J].
GRYGLEWSKI, RJ .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1993, 19 (02) :158-166
[10]   NITRIC-OXIDE MODULATES VASCULAR TONE IN PREGLOMERULAR ARTERIOLES [J].
IMIG, JD ;
ROMAN, RJ .
HYPERTENSION, 1992, 19 (06) :770-774